117 related articles for article (PubMed ID: 28404964)
1. Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.
Ng L; Wan TM; Man JH; Chow AK; Iyer D; Chen G; Yau TC; Lo OS; Foo DC; Poon JT; Leung WK; Pang RW; Law WL
Oncotarget; 2017 Apr; 8(16):27393-27400. PubMed ID: 28404964
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological utility of miR-203a-3p in diagnosing colorectal cancer.
Qasemi Rad M; Pouresmaeil V; Hosseini Mojahed F; Amirabadi A; Aalami AH
Mol Biol Rep; 2022 Jul; 49(7):6975-6985. PubMed ID: 35511316
[TBL] [Abstract][Full Text] [Related]
3. Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma.
Li J; Liu Y; Wang C; Deng T; Liang H; Wang Y; Huang D; Fan Q; Wang X; Ning T; Liu R; Zhang CY; Zen K; Chen X; Ba Y
Sci Rep; 2015 Aug; 5():12921. PubMed ID: 26250939
[TBL] [Abstract][Full Text] [Related]
4. Plasma miRNA can detect colorectal cancer, but how early?
Wikberg ML; Myte R; Palmqvist R; van Guelpen B; Ljuslinder I
Cancer Med; 2018 May; 7(5):1697-1705. PubMed ID: 29573205
[TBL] [Abstract][Full Text] [Related]
5. miRNA as a Biomarker for the Early Detection of Colorectal Cancer.
Coleman D; Kuwada S
Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540397
[TBL] [Abstract][Full Text] [Related]
6. Tumor circulating biomarkers in colorectal cancer.
Bagheri R; Ghorbian M; Ghorbian S
Cancer Treat Res Commun; 2024; 38():100787. PubMed ID: 38194840
[TBL] [Abstract][Full Text] [Related]
7. Effects of High-Flux Dialysis Combined with Hemoperfusion on Serum GRP78 and miR-495-3p in Renal Failure Patients.
Fan W; Li X; Xu X; Chu H
Biomed Res Int; 2021; 2021():9591177. PubMed ID: 34671680
[TBL] [Abstract][Full Text] [Related]
8. AP4 induces JNK1 and a miR-22-3p/FOSL1 feed-forward loop to activate AP-1 and promote colorectal cancer metastasis.
Chou J; Kaller M; Rokavec M; Liu F; Hermeking H
Cancer Commun (Lond); 2024 Mar; 44(3):433-437. PubMed ID: 38225895
[No Abstract] [Full Text] [Related]
9. Retracted: Expression Levels and Clinical Significance of Serum miR-497, CEA, CA24-2, and HBsAg in Patients with Colorectal Cancer.
International BR
Biomed Res Int; 2024; 2024():9876010. PubMed ID: 38230108
[TBL] [Abstract][Full Text] [Related]
10. Correction to: N6‑methyladenosine levels in peripheral blood RNA: a potential diagnostic biomarker for colorectal cancer.
Zhang C; Chen J; Ren J; Li X; Zhang Y; Huang B; Xu Y; Dong L; Cao Y
Cancer Cell Int; 2024 Apr; 24(1):126. PubMed ID: 38581005
[No Abstract] [Full Text] [Related]
11. The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis.
Peng Q; Zhang X; Min M; Zou L; Shen P; Zhu Y
Oncotarget; 2017 Jul; 8(27):44893-44909. PubMed ID: 28415652
[TBL] [Abstract][Full Text] [Related]
12. Serum miR-20a is a promising biomarker for gastric cancer.
Yang R; Fu Y; Zeng Y; Xiang M; Yin Y; Li L; Xu H; Zhong J; Zeng X
Biomed Rep; 2017 Apr; 6(4):429-434. PubMed ID: 28413641
[TBL] [Abstract][Full Text] [Related]
13. The miR-124-p63 feedback loop modulates colorectal cancer growth.
Liu K; Yao H; Lei S; Xiong L; Qi H; Qian K; Liu J; Wang P; Zhao H
Oncotarget; 2017 Apr; 8(17):29101-29115. PubMed ID: 28418858
[TBL] [Abstract][Full Text] [Related]
14. Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.
Liu B; Su F; Chen M; Li Y; Qi X; Xiao J; Li X; Liu X; Liang W; Zhang Y; Zhang J
Hum Pathol; 2017 Jun; 64():44-52. PubMed ID: 28412211
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of miR-506 and miR-4316 expression in early and non-invasive diagnosis of colorectal cancer.
Krawczyk P; Powrózek T; Olesiński T; Dmitruk A; Dziwota J; Kowalski D; Milanowski J
Int J Colorectal Dis; 2017 Jul; 32(7):1057-1060. PubMed ID: 28405738
[TBL] [Abstract][Full Text] [Related]
16. Serum MicroRNA profile in patients with colon adenomas or cancer.
Zhang Y; Li M; Ding Y; Fan Z; Zhang J; Zhang H; Jiang B; Zhu Y
BMC Med Genomics; 2017 Apr; 10(1):23. PubMed ID: 28427387
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNAs as novel biomarkers of ALK-positive nonsmall cell lung cancer and predictors of response to crizotinib therapy.
Li LL; Qu LL; Fu HJ; Zheng XF; Tang CH; Li XY; Chen J; Wang WX; Yang SX; Wang L; Zhao GH; Lv PP; Zhang M; Lei YY; Qin HF; Wang H; Gao HJ; Liu XQ
Oncotarget; 2017 Jul; 8(28):45399-45414. PubMed ID: 28514730
[TBL] [Abstract][Full Text] [Related]
18. Novel insights on perils and promises of miRNA in understanding colon cancer metastasis and progression.
Tariq L; Arafah A; Sehar N; Ali A; Khan A; Rasool I; Rashid SM; Ahmad SB; Beigh S; Dar TUH; Rehman MU
Med Oncol; 2023 Aug; 40(10):282. PubMed ID: 37639075
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA Biomarkers as Promising Tools for Early Colorectal Cancer Screening-A Comprehensive Review.
Santos DAR; Gaiteiro C; Santos M; Santos L; Dinis-Ribeiro M; Lima L
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446201
[TBL] [Abstract][Full Text] [Related]
20. Cross-Kingdom Interaction of miRNAs and Gut Microbiota with Non-Invasive Diagnostic and Therapeutic Implications in Colorectal Cancer.
Pös O; Styk J; Buglyó G; Zeman M; Lukyova L; Bernatova K; Hrckova Turnova E; Rendek T; Csók Á; Repiska V; Nagy B; Szemes T
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
